The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity ...

Transcatheter Aortic Valve Replacement Market outlook through 2035, highlighting key trends, growth drivers, challenges, and future opportunities ...

For patients with symptomatic aortic regurgitation at high surgical risk, a transcatheter aortic valve replacement system ...

According to the company, the system exhibited “durable” clinical results and “strong” valve ... with severe aortic stenosis who underwent treatment with either the Evolut TAVR or surgery ...

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

This can be done with traditional, open-heart surgery or with a relatively newer procedure known as transcatheter aortic valve replacement (TAVR). You don’t have your chest opened with TAVR.

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling ...

Aortic valve stenosis' is an often-overlooked condition ... transcatheter aortic valve replacement (TAVR) - a less invasive procedure - is a viable alternative. Two Main Valve Replacement Options ...

The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...

Edwards Lifesciences Corp.’s additional insights from the Early TAVR trial showed a clear benefit for transcatheter aortic valve replacement (TAVR) in patients with asymptomatic aortic stenosis.

“These patients already had their TAVR,” he said. “So, [is] this related somewhat to the device that may have been used? The operators? The patients themselves? How do you explain that higher stroke ...

CHICAGO -- Transcatheter aortic valve replacement (TAVR ... In people with severe aortic stenosis (AS) deemed suitable for either procedure, the combined endpoint of all-cause mortality and ...